Sanofi is a French company headquartered in Paris, focused on vaccines, immunology, rare diseases and, historically, diabetes, with the immunology blockbuster Dupixent for asthma and eczema among its leading products.
Sanofi has been shifting toward immunology and vaccines while losing insulin market share and facing pricing pressure.
